Orion Investment Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37M Buy
22,553
+405
+2% +$23.6K 0.43% 39
2025
Q4
$1.19M Sell
22,148
-2,310
-9% -$111K 0.36% 42
2025
Q3
$1.1M Sell
24,458
-750
-3% -$35K 0.35% 40
2025
Q2
$1.17M Sell
25,208
-4
-0% -$196 0.41% 38
2025
Q1
$1.54M Sell
25,212
-8
-0% -$466 0.63% 31
2024
Q4
$1.43M Hold
25,220
0.57% 30
2024
Q3
$1.3M Sell
25,220
-185
-0.7% -$8.68K 0.51% 30
2024
Q2
$1.06M Buy
+25,405
New +$1.14M 0.42% 32

Other funds holding BMY

Orion Investment Company's BMY Position: Q1 2026 in Review

Orion Investment Company increased its Bristol-Myers Squibb (BMY) stake by 1.8% in Q1 2026, buying an estimated $23.6K and bringing the position to 22,553 shares worth $1.37M. The position accounts for 0.43% of the portfolio, ranked #39.

Orion Investment Company first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.54M in Q1 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Orion Investment Company held 22,553 shares of Bristol-Myers Squibb worth $1.37M as of Q1 2026.
  • Orion Investment Company bought 405 Bristol-Myers Squibb shares in Q1 2026, an estimated $23.6K.
  • Bristol-Myers Squibb made up 0.43% of Orion Investment Company's portfolio in Q1 2026, its #39 holding.
  • Orion Investment Company first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
  • Orion Investment Company's Bristol-Myers Squibb position peaked at $1.54M in Q1 2025.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Orion Investment Company's 13F filing for Q1 2026, filed 12 May 2026.